ArticleFEBS open bio2026
Heterotropic regulation and negative homotropic cooperativity.
Article in FEBS open bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Heterotropic regulation of protein function is crucial for such diverse cellular events as transcription, signal transduction, enzymatic activity, transport and many others. It is achieved via ligand-induced changes in protein structure and is often coupled to homotropic cooperativity. In this work, we compare the structural and functional properties of a set of evolutionarily unrelated proteins that present heterotropic regulation and negative homotropic cooperativity, for at least some of their ligands. This set is limited because the coupling of negative cooperativity and heterotropic regulation occurs rarely. Nevertheless, we identified some recurring structural features among the proteins in our dataset. All of these proteins: (i) are homo-oligomers; (ii) have a one ligand per subunit binding stoichiometry both for their primary ligands/substrates and their effectors; (iii) do not require complete saturation with their effectors to reach maximum activation or inhibition; and (iv) show peculiar intersubunit ligand-induced asymmetry. Together, these results imply that heterotropic regulation acts at the quaternary, as well as tertiary, structure level.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.